Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term

According to Zacks Investment Research, HCA Healthcare (HCA), the largest non-governmental hospital operator in the U.S., is a compelling value stock. HCA holds a Zacks Rank #3 (Hold) with a VGM Score of A and a Value Style Score of A, supported by a forward P/E ratio of 14.73; furthermore, nine analysts have raised their FY25 earnings estimates in the last 60 days, increasing the consensus estimate to $25.28 per share.

Analysis

HCA Healthcare (HCA), the largest non-governmental operator of acute care hospitals in the United States with 190 hospitals and approximately 2,400 ambulatory sites of care as of the end of 2024, is highlighted as a notable value stock. Despite carrying a Zacks Rank #3 (Hold), HCA exhibits strong underlying metrics according to the Zacks Style Score system, achieving an 'A' for its overall VGM (Value, Growth, Momentum) Score and an 'A' for its Value Style Score. This strong value assessment is supported by a forward Price-to-Earnings (P/E) ratio of 14.73. Reinforcing a positive outlook, nine analysts have revised their earnings estimates upward for fiscal 2025 within the past 60 days, leading to an increase in the Zacks Consensus Estimate by $0.36 to $25.28 per share. Furthermore, HCA has a track record of exceeding earnings expectations, with an average earnings surprise of 7.1%. The article's strongly positive sentiment (overall score 0.75, HCA-specific 0.85) underscores the argument that HCA's solid fundamentals and favorable valuation make it a compelling candidate for investors' consideration, particularly within a value-oriented investment strategy.

Key Decisions for Investors

• Investors should consider HCA Healthcare for its strong value characteristics, evidenced by its 'A' Value Style Score and a forward P/E of 14.73, which suggest it may be undervalued despite its current Zacks #3 (Hold) rating.
• The positive revisions to FY25 earnings estimates, with the consensus EPS rising to $25.28 following nine analyst upgrades, alongside a consistent 7.1% average earnings surprise, indicate underlying fundamental strength and potential for positive stock performance.
• Given the combination of a 'Hold' rank with top-tier Value and VGM scores ('A'), HCA warrants inclusion on a watchlist for potential accumulation, particularly if broader market conditions favor value stocks or if further positive catalysts emerge for the company or healthcare sector.